How to Value a Startup Equity Package Against a Public Company RSU Offer
Convert startup options and public RSUs to comparable expected values accounting for risk.
Comparing a startup equity package with a public-company RSU offer means comparing uncertain upside with shares that can become spendable cash. The headline grant values do not settle the choice. Engineers need to put both offers on the same scale by accounting for purchase costs, dilution, failure risk, time to liquidity and taxes, then compare the resulting expected values.
Why a startup equity offer and a public-company RSU offer cannot be compared as written
An engineer holds two offer letters, sees an equity number on each and reaches for a calculator. The instinct is sensible, but the numbers describe different things. A public-company RSU promises shares at vesting without a purchase. A startup option gives the engineer the right to buy shares at a fixed strike price. Subtracting one headline value from the other hides that difference.
Public-company RSUs have a market price when they vest and can be sold for cash. Options require an exercise payment, and the resulting private shares may remain unsellable. If the company never exits or exits below the strike price, the options can expire worthless. The startup also concentrates risk because salary, equity and future upside all depend on the same business.
The three instrument types an engineer is likely to encounter in 2026 and what each one actually delivers
The first diagnostic step is to identify the instrument. Incentive stock options, or ISOs, are standard at early-stage startups and are available only to employees. They can lower the tax bill if the conditions are met, but can also lead to alternative minimum tax, or AMT. An annual cap limits how much grant value can vest with ISO treatment, with amounts above it becoming nonqualified stock options.
Nonqualified stock options, or NSOs, also appear in grants to contractors and advisors. Their defining difference is ordinary income tax on the spread at exercise, even if the shares cannot be sold. Restricted stock units, or RSUs, are the most common form of equity in public and late-stage offers, and more growth-stage companies now offer them to senior hires. Private-company RSUs require another distinction because time-based vesting and liquidity conditions affect when tax becomes due.
Some organizations that do frontier AI research use profit participation units or profit interests instead. Those need their own analysis of what they pay and how they are taxed, outside an options-versus-RSUs calculation. Once the instrument is clear, the next input is the price at which it was set.
How 409A valuations set the strike price and why the common-stock discount is the first number to understand
A private company has no stock ticker, so its 409A valuation supplies an appraisal of common-stock value. That appraisal anchors the option strike price. It is not the same as the preferred price investors paid in the last funding round. Preferred shares have rights that employee common shares do not have, including liquidation preferences and anti-dilution protections. The common-stock discount reflects that difference.
At an early-stage startup, the 409A may be a small fraction of the preferred price. Near an IPO, the gap can narrow substantially. A low strike price relative to a much higher eventual exit price creates option upside, but the preferred price is not a promise to employees. Investors’ liquidation preferences must be paid before common shareholders get any money from an acquisition. So even an acquisition at a high price can leave employee shares worth nothing.
Knowing both the 409A and the last preferred price makes the grant easier to interpret. Early exercise and an 83(b) election are also tools worth understanding when the gap between common-stock value and strike price is small. The election has a hard 30-day filing deadline. Its tax effects belong later in the comparison, after the initial estimate of paper value.
The dilution and failure-rate discounts that reduce paper equity to an expected-value number
Each funding round issues new shares and dilutes existing holders. The business may become more valuable while the engineer owns a smaller share of it. That is why the number of options says little on its own without the total fully diluted share count. A valuation model must allow for the ownership percentage to shrink before exit.
Survival creates a separate discount. A large majority of venture-funded startups fail to return cash to investors, and acquisitions are more common than IPOs. Even a company that survives must exit at a price high enough to pay preferred claims and still leave a worthwhile sum for common shareholders. Expected value weights each possible payout by how likely it is, so a good outcome counts only in proportion to its chance of happening.
Stage helps organize these risks. Seed and Series A grants face the most failure risk and dilution, but often have the lowest strikes. Series B/C grants have less risk ahead but also have less to gain from a low exercise price. Series D+ equity can look more RSU-like, but remains private until liquidity arrives. At that stage, an uncompetitive salary weakens the case because the engineer is still accepting risk without the same early-stage upside.
A step-by-step framework for converting both offers into a comparable expected-value number
Start by getting answers to five non-negotiable questions. What percentage of fully diluted shares does the grant represent. What are the 409A valuation and last preferred price. What is the full vesting schedule, including the cliff and vesting cadence. What are the strike price and post-departure exercise window. Does vesting accelerate on acquisition, and does acceleration require a sale alone or a sale plus termination.
Next, calculate the startup grant’s paper spread. Multiply the fully diluted ownership percentage by an assumed company valuation, then subtract the strike price multiplied by the option count. The last preferred valuation can serve as a starting scenario, but the payout it gives for employees is too uncertain to rely on. The calculation assumes no further dilution and does not establish what remains after preferred claims. Keep those limits visible.
For a worked comparison, take a Series B/C option offer against a public-company RSU offer. Begin with the startup’s current ownership percentage, then reduce it for funding expected before exit. Multiply each assumed exit valuation by that smaller percentage, allow for preferred claims, then subtract the costs of exercise. Include a failure case where the grant pays nothing. Weight the payout scenarios by their probability and apply an illiquidity discount for the wait before the money becomes usable.
Then calculate the public offer’s annual equity value by dividing its total grant value, at the current stock price, by its vesting period in years. Add the refresh grants expected to vest to the pay for Year 2+ as they vest. Public companies usually give refreshes, while startup grants usually have no such built-in top-up. The public share price can change, so this side is also a scenario.
Now divide the startup’s risk-adjusted equity value by its vesting years and add startup base salary. Add the public-company base salary to the RSU value for each year, with refreshes counted over the same period. Keeping the employment horizon consistent prevents a large multiyear grant from being compared with one year of pay.
Finally, solve for the exit valuation at which the startup package matches the public offer under the chosen assumptions. That crossover is more useful than the headline grant value. Below it, the public offer wins financially, while above it the startup can pull ahead. Run several scenarios. The key judgment is whether the company can plausibly reach the required outcome.
How tax treatment changes the after-tax outcome for each instrument and why it must enter the comparison last
Tax comes last because the instrument, exercise timing, payout and holding period determine what gets taxed. It can still reverse the result. Public-company RSUs become ordinary income at their vesting-date value. Employer withholding covers part of the bill, but withholding is not the final liability. Apply the engineer’s relevant marginal rate to that income, with later share appreciation treated separately as capital gains.
ISOs can receive long-term capital gains treatment when the required holding periods are met, which are one year after exercise and two years after grant. However, the spread at exercise can trigger AMT before any shares are sold. The comparison therefore needs both an eventual after-tax gain and a buffer for exercise-year cash needs. Early exercise when the spread is small or zero, paired with a timely 83(b) election where applicable, can reduce that exposure. It does not remove the risk of buying shares that never become valuable.
NSOs create ordinary income on the exercise spread regardless of liquidity, followed by capital gains treatment on subsequent appreciation. Verify that structure before accepting private RSUs. For early-stage grants, a potential tax exclusion is another material variable for a tax-advisor conversation. These differences make grant structure part of the negotiation.
What has changed in 2026 that shifts the expected value of startup equity upward for a specific subset of offers
The discounts should reflect the current company and market. In the first half of 2026, more venture-backed companies listed than in the comparable period of 2025, and the dollar value of listings was substantially higher. A reopened IPO window can shorten expected time to liquidity for growth-stage and late-stage holders. It does much less for an early-stage company that still has to build a viable business.
Terms have also improved for some offers. More Series B through growth-stage companies now give employees post-departure exercise windows of 7 to 10 years, though most still allow only 90 days. Tender offers at well-funded growth-stage companies can provide partial liquidity before an exit. Those terms lower some of the risks in the framework, but private equity still has risks that cash does not.
AI-adjacent offers need particular care because strong traction and better access to liquidity can support a smaller discount. High funding valuations cut the other way when they produce higher strike prices and less room for option gains. A well-positioned company can be a genuine outlier without making every AI startup a good bet. Profit-based instruments at frontier research organizations still require separate analysis, even where tender offers have made employee liquidity more practical.
The terms engineers can actually negotiate and which ones move the expected value most
The calculation shows which requests matter. Grant percentage has the broadest reach because it multiplies the proceeds in every successful scenario. A higher percentage raises the upside, while a longer exercise window gives an engineer more time to decide whether to put in cash after leaving. Senior engineers can negotiate both, and early-stage AI and ML hires central to the product have a basis for a higher grant ask. The discussion is about the economics of the role.
A 90-day window can force an engineer to exercise or forfeit before the outcome is clear. Asking for 7–10 years preserves more freedom to wait. Acquisition acceleration addresses another risk. Single-trigger acceleration takes effect on a sale alone, while double-trigger acceleration takes effect only if there is also a termination. Senior hires and founding engineers can reasonably ask for partial single-trigger acceleration of a meaningful portion of unvested shares.
The cliff, early exercise rights and refresh grants also deserve attention. Experienced hires can ask for changes to the standard one-year cliff, including a 6-month cliff or credit for relevant prior experience. Engineers who join early-stage companies should make asking for early exercise rights a standard part of the offer discussion. A commitment to annual or biennial performance-linked refreshes can partly close the public-company advantage. A company unwilling to answer the five non-negotiable questions before signing is itself giving a signal about the relationship ahead.
How to make the final call when the expected values are close
If the startup package is materially worse after tax, the public offer wins on expected value. If matching it requires an exit valuation the engineer does not believe, the headline upside does not rescue the offer.
Risk tolerance starts with finances: liquid savings can make a failed startup bet bearable, while a mortgage, dependents or debt can make the same bet costly. Any salary sacrifice is certain, while equity upside is not. Investor quality, revenue growth, product-market fit and the founding team then help distinguish this company from the broad failure rate.
The role itself can also create value through scope, ownership and difficult technical work. A track record of solving a hard problem can open doors even when equity disappoints. If the startup offers more compelling work, a better team and a problem that matters more to the engineer, a small financial gap may be worth accepting when it is affordable. But startup equity remains a long-duration bet. The right choice is one whose economics are understood, whose downside is bearable and whose work is worth staying for.